Status:
UNKNOWN
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
Lead Sponsor:
University of L'Aquila
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
People affected by SARS-CoV-2 infection, whether patients have developed mild forms or a severe form of the disease, complain of nonspecific and entirely new symptoms or complain about the persistence...
Eligibility Criteria
Inclusion
- Patients over 18
Exclusion
- Patients under 18
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05359159
Start Date
February 1 2021
End Date
February 1 2024
Last Update
December 5 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clara Balsano
L’Aquila, Italy/L'Aquila, Italy, 67100
2
University of L'Aquila
L’Aquila, Italy, 67100